Essity AB: A Resilient Consumer Compounder with Margin Recovery and Innovation Catalysts

Essity AB (ESSITY-B.ST) is a leading global hygiene and health company with strong brands in tissue, personal care, and incontinence products. The company is benefiting from a margin recovery driven by cost savings and price increases, while its innovation in sustainable and premium products supports volume growth. With a solid balance sheet and a dividend yield of around 3%, Essity offers a defensive yet growing profile in the consumer staples space.

Thesis

Essity is a consumer compounder with a wide moat in essential hygiene products. The company is executing a margin improvement program (targeting 15%+ EBITA margin by 2025) and investing in high-growth categories like incontinence and professional hygiene. Its focus on sustainability and digitalization should drive market share gains.

12-Month Catalysts

  • Continued margin expansion from cost savings and premiumization.
  • Innovation in sustainable products (e.g., plant-based materials) driving volume growth.
  • Potential M&A or divestitures to streamline portfolio.

Key Risks

  • Raw material cost inflation (pulp, energy) could pressure margins.
  • Intense competition from private labels and larger peers like Procter & Gamble.

Disclaimer: This is not financial advice. Please conduct your own research before investing.